AAAAAA

   
Results: 1-13 |
Results: 13
MABS TO THE EXTRACELLULAR DOMAIN OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)
Authors: LIU H RAJASEKARAN A SCHEINBERG D SGOUROS G GEERLINGS M VALLABHAJOSULA S HAMILTON A KING S CARR F BANDER N
Citation: H. Liu et al., MABS TO THE EXTRACELLULAR DOMAIN OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA), CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 2-2
NEUTRAL ENDOPEPTIDASE-24.11 LOSS IN METASTATIC HUMAN PROSTATE-CANCER CONTRIBUTES TO ANDROGEN-INDEPENDENT PROGRESSION
Authors: PAPANDREOU CN USMANI B GENG YP BOGENRIEDER T FREEMAN R WILK S FINSTAD CL REUTER VE POWELL CT SCHEINBERG D MAGILL C SCHER HI ALBINO AP NANUS DM
Citation: Cn. Papandreou et al., NEUTRAL ENDOPEPTIDASE-24.11 LOSS IN METASTATIC HUMAN PROSTATE-CANCER CONTRIBUTES TO ANDROGEN-INDEPENDENT PROGRESSION, Nature medicine, 4(1), 1998, pp. 50-57
A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULTPATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: WEISS MA DRULLINSKY P MASLAK P SCHEINBERG D GOLDE DW
Citation: Ma. Weiss et al., A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULTPATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia, 12(6), 1998, pp. 865-868
ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML RAR-ALPHA INDEPENDENT MANNER/
Authors: WANG ZG RIVI R DELVA L KONIG A SOIGNET S SCHEINBERG D GAMBACORTIPASSERINI C GABRILOVE JL WARRELL RP PANDOLFI PP
Citation: Zg. Wang et al., ARSENIC TRIOXIDE AND MELARSOPROL INDUCE PROGRAMMED CELL-DEATH IN MYELOID-LEUKEMIA CELL-LINES AND FUNCTION IN A PML AND PML RAR-ALPHA INDEPENDENT MANNER/, Blood, 90(10), 1997, pp. 1461-1461
CYTARABINE WITH HIGH-DOSE MITOXANTRONE INDUCES RAPID COMPLETE REMISSIONS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA WITHOUT THE USE OF VINCRISTINE OR PREDNISONE
Authors: WEISS M MASLAK P FELDMAN E BERMAN E BERTINO J GEE T MEGHERIAN L SEITER K SCHEINBERG D GOLDE D
Citation: M. Weiss et al., CYTARABINE WITH HIGH-DOSE MITOXANTRONE INDUCES RAPID COMPLETE REMISSIONS IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA WITHOUT THE USE OF VINCRISTINE OR PREDNISONE, Journal of clinical oncology, 14(9), 1996, pp. 2480-2485
ORGANIC ARSENICAL MELARSOPROL SHOWS GROWTH SUPPRESSIVE ACTIVITY VIA PROGRAMMED CELL-DEATH ON APL AND OTHER MYELOID AND LYMPHOID LEUKEMIA-DERIVED CELL-LINES
Authors: RIVI R CALLEJA E KONIG A LAI L GAMBACORTIPASSERINI C SCHEINBERG D GABRILOVE JL WARRELL RP PANDOLFI PP
Citation: R. Rivi et al., ORGANIC ARSENICAL MELARSOPROL SHOWS GROWTH SUPPRESSIVE ACTIVITY VIA PROGRAMMED CELL-DEATH ON APL AND OTHER MYELOID AND LYMPHOID LEUKEMIA-DERIVED CELL-LINES, Blood, 88(10), 1996, pp. 260-260
CONSOLIDATION THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) REDUCES MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH FLUDARABINE AS INDUCTION THERAPY
Authors: WEISS M GLENN M MASLAK P RAHMAN Z MEGHERIAN L NOY A ZELENETZ A SCHEINBERG D GOLDE D
Citation: M. Weiss et al., CONSOLIDATION THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) REDUCES MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH FLUDARABINE AS INDUCTION THERAPY, Blood, 88(10), 1996, pp. 1911-1911
A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE (ARA-C) AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
Authors: WEISS M MASLAK P MEGHERIAN L SCHEINBERG D
Citation: M. Weiss et al., A PHASE-I TRIAL OF A SINGLE HIGH-DOSE OF IDARUBICIN COMBINED WITH HIGH-DOSE CYTARABINE (ARA-C) AS INDUCTION THERAPY IN RELAPSED OR REFRACTORY ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 86(10), 1995, pp. 3131-3131
CURRENT STATUS OF RADIOIMMUNOTHERAPY
Authors: LARSON SM DIVGI CR SCOTT A SGOUROS G GRAHAM MC KOSTAKOGLU L SCHEINBERG D CHEUNG NKV SCHLOM J FINN RD
Citation: Sm. Larson et al., CURRENT STATUS OF RADIOIMMUNOTHERAPY, Nuclear medicine and biology, 21(5), 1994, pp. 785-792
SEVERE TOXICITY LIMITS INTENSIFICATION OF INDUCTION THERAPY FOR ACUTELYMPHOBLASTIC-LEUKEMIA
Authors: WEISS M TELFORD P KEMPIN S KRITZ A SOGOLOFF H GEE T BERMAN E SCHEINBERG D LITTLE C GAYNOR J BELANGER C BERTINO J ANDREEFF M MCKENZIE S CLARKSON B
Citation: M. Weiss et al., SEVERE TOXICITY LIMITS INTENSIFICATION OF INDUCTION THERAPY FOR ACUTELYMPHOBLASTIC-LEUKEMIA, Leukemia, 7(6), 1993, pp. 832-837
COOPERATION BETWEEN RETINOIC ACID AND PHORBOL ESTERS ENHANCES HUMAN TERATOCARCINOMA DIFFERENTIATION
Authors: KURIE JM BROWN P SALK E SCHEINBERG D BIRRER M DEUTSCH P DMITROVSKY E
Citation: Jm. Kurie et al., COOPERATION BETWEEN RETINOIC ACID AND PHORBOL ESTERS ENHANCES HUMAN TERATOCARCINOMA DIFFERENTIATION, Differentiation, 54(2), 1993, pp. 115-122
RAPID REMISSION INDUCTION THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITHOUT VINCRISTINE OR PREDNISONE
Authors: WEISS M BERMAN E MASLAK P BERTINO J CLARKSON B NICHOLS G ALVAREZ A GEE T SCHEINBERG D GOLDE D
Citation: M. Weiss et al., RAPID REMISSION INDUCTION THERAPY IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) WITHOUT VINCRISTINE OR PREDNISONE, Blood, 82(10), 1993, pp. 10000056-10000056
COMBINATION OF BIOLOGIC AGENTS WITH CHEMOTHERAPY LIMITS TOXICITY IN THE TREATMENT OF ELDERLY PATIENTS WITH AML
Authors: MASLAK P WEISS M NICHOLS G TYSON D GEE T BERMAN E SCHEINBERG D
Citation: P. Maslak et al., COMBINATION OF BIOLOGIC AGENTS WITH CHEMOTHERAPY LIMITS TOXICITY IN THE TREATMENT OF ELDERLY PATIENTS WITH AML, Blood, 82(10), 1993, pp. 10000130-10000130
Risultati: 1-13 |